Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 1.02M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
10: R1 Cover HTML 69K
11: R2 Condensed Consolidated Statements of Operations HTML 85K
Unaudited
12: R3 Condensed Consolidated Balance Sheets Unaudited HTML 112K
13: R4 Condensed Consolidated Balance Sheets HTML 35K
(Parenthetical)
14: R5 Condensed Consolidated Statements of Comprehensive HTML 44K
Loss Unaudited
15: R6 Condensed Consolidated Statements of Cash Flows HTML 89K
Unaudited
16: R7 Condensed Consolidated Statements of Stockholders' HTML 81K
Equity
17: R8 Accounting Policies HTML 51K
18: R9 Nature of Business and Basis of Presentation HTML 32K
19: R10 Basic and Diluted Net Loss Per Share HTML 28K
20: R11 Investments HTML 37K
21: R12 Fair Value Measurements HTML 50K
22: R13 Accrued Expenses HTML 27K
23: R14 Stock-Based Compensation HTML 37K
24: R15 Leases HTML 46K
25: R16 Commitments and Contingencies HTML 27K
26: R17 License Agreements HTML 21K
27: R18 Geographic Information HTML 42K
28: R19 Capital Stock and Warrants HTML 42K
29: R20 Accounting Policies (Policies) HTML 93K
30: R21 Accounting Policies (Tables) HTML 37K
31: R22 Basic and Diluted Net Loss Per Share (Tables) HTML 26K
32: R23 Investments (Tables) HTML 36K
33: R24 Fair Value Measurements (Tables) HTML 47K
34: R25 Accrued Expenses (Tables) HTML 26K
35: R26 Stock-Based Compensation (Tables) HTML 35K
36: R27 Leases (Tables) HTML 44K
37: R28 Geographic Information (Tables) HTML 39K
38: R29 Capital Stock and Warrants (Tables) HTML 43K
39: R30 ACCOUNTING POLICIES - Additional Information HTML 35K
(Details)
40: R31 ACCOUNTING POLICIES - Schedule of Cash And HTML 27K
Restricted Cash (Details)
41: R32 Nature of Business and Basis of Presentation HTML 20K
(Details)
42: R33 Basic and Diluted Net Loss Per Share (Details) HTML 27K
43: R34 Investments (Details) HTML 30K
44: R35 FAIR VALUE MEASUREMENTS - Assets and Liabilities HTML 45K
Measured at Fair Value on a Recurring Basis
(Details)
45: R36 Accrued Expenses (Details) HTML 29K
46: R37 Stock-Based Compensation (Details) HTML 82K
47: R38 Stock-Based Compensation - RSU Activity (Details) HTML 28K
48: R39 LEASES - Narrative (Details) HTML 31K
49: R40 LEASES - Maturity Analysis of Lease Liabilities HTML 38K
(Details)
50: R41 LEASES - Quantitative Disclosure of Lease Costs HTML 33K
(Details)
51: R42 Commitments and Contingencies (Details) HTML 32K
52: R43 Geographic Information (Details) HTML 31K
53: R44 CAPITAL STOCK AND WARRANTS - Narrative (Details) HTML 39K
54: R45 CAPITAL STOCK AND WARRANTS - Schedule Of Warrants HTML 34K
Issuance (Details)
55: R46 CAPITAL STOCK AND WARRANTS - Schedule of Common HTML 25K
Stock Reserved For Future Issuance (Details)
58: XML IDEA XML File -- Filing Summary XML 103K
56: XML XBRL Instance -- yten-20220930_htm XML 1.11M
57: EXCEL IDEA Workbook of Financial Reports XLSX 100K
6: EX-101.CAL XBRL Calculations -- yten-20220930_cal XML 135K
7: EX-101.DEF XBRL Definitions -- yten-20220930_def XML 311K
8: EX-101.LAB XBRL Labels -- yten-20220930_lab XML 1.05M
9: EX-101.PRE XBRL Presentations -- yten-20220930_pre XML 584K
5: EX-101.SCH XBRL Schema -- yten-20220930 XSD 96K
59: JSON XBRL Instance as JSON Data -- MetaLinks 296± 448K
60: ZIP XBRL Zipped Folder -- 0001121702-22-000049-xbrl Zip 259K
1.I have reviewed this Quarterly Report on Form 10-Q of Yield10 Bioscience, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting
to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the
registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s
board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
